Mr. Sydney Au reports

AUXELLENCE HEALTH EARLY WARNING REPORT

Sydney Au, the chief executive officer and director of Auxellence Health Corp., has acquired common shares and share purchase warrants pursuant to Section 2.12 of National Instrument 45-106 (prospectus and registration exemptions) in connection with Auxellence's recently announced non-brokered private placement of units of Auxellence at a price per unit of five cents, with each unit consisting of one common share and one common share purchase warrant of the company, with each such warrant entitling the holder to purchase an additional common share of the company at a price of 10 cents. All such securities issued by the company are subject to a four-month statutory hold period.

As a result of the foregoing, the securityholder acquired 2.68 million common shares and 2.68 million share purchase warrants.

Prior to the private placement, the securityholder beneficially owned 23.2 million common shares, including shares optioned to third parties that have not been exercised.

As a result of the private placement, the securityholder acquired 2.68 million units, and now the securityholder beneficially owns 25.88 million common shares or 24.56 per cent of the company's current issued and outstanding common shares, representing 105,379,284 common shares. Should the securityholder exercise the warrants in full to purchase an additional 2.68 million common shares, the securityholder then would beneficially own 28.56 million common shares or 22.25 per cent of the company's then fully diluted issued and outstanding common shares, representing 128,380,884 common shares. The securityholder has acquired the common shares for investment purposes.

This press release is being issued pursuant to National Instrument 62-103 (the early warning system and related takeover bid and insider reporting issuers), which requires a report to be filed under the corporation's profile on SEDAR containing additional information respecting the foregoing matters.